CommercialCoverageMedium impact
Supporting metabolic health and psychosocial care for patients taking antipsychotic medications
Cigna·Psychiatry, Pediatrics, Internal Medicine +1 more·Coverage
Effective date
Sep 1, 2026
We identified it
Sep 2, 2026
Summary
This is a new clinical guidance policy (effective September 1, 2026) from Cigna Healthcare recommending metabolic screening and psychosocial care for patients on antipsychotic medications. The policy emphasizes quarterly monitoring for weight, glucose, HbA1c, and cholesterol, plus psychosocial interventions for children and adolescents. This is a coverage and care coordination policy, not a billing code change.
Action Required
By September 1, 2026: (1) Billing team should verify with Cigna Healthcare whether metabolic screening services (lab work, weight/BMI measurements) require prior authorization or have specific billing codes for antipsychotic monitoring. (2) Clinical staff must ensure encounter documentation includes: completed metabolic screenings (weight, glucose, HbA1c, cholesterol), psychosocial service referrals, and patient education provided. (3) Front-desk/scheduling staff should flag antipsychotic patients for quarterly metabolic monitoring reminders. (4) Providers should coordinate with behavioral health (contact Evernorth Behavioral Health at 800.926.2273 for referrals and eligibility). Without proper documentation and coordination, claims for associated services may be denied or patients may not receive appropriate covered preventive services.